Chiral Method Development & Purification: Design and execute chiral separation techniques using SFC and Normal Phase chromatography to purify enantiomers.
Instrument Operation & Maintenance: Independently operate SFC and other chromatographic instruments, ensuring regular calibration and maintenance to uphold performance standards.
Collaboration with Synthetic Teams: Work closely with synthetic chemists to understand compound structures and optimize purification processes.
Documentation & Compliance: Maintain accurate records of experiments, adhering to Good Laboratory Practices (GLP) and ensuring compliance with regulatory standards.
Additional Analytical Tasks: Perform chiral screening and other analytical procedures as required to support ongoing projects.
Performance Bonus: Some roles may include annual or project-based incentives.
Provident Fund & Gratuity: As per Indian labor laws, ensuring retirement savings.
Medical Insurance: Coverage for the employee and sometimes for dependents.
Life Insurance: Basic life cover provided by the organization.
Wellness Programs: Initiatives for physical and mental well-being may be available.
Paid Time Off (PTO): Annual leave, sick leave, and national holidays.
Flexible Working Hours: Some flexibility depending on project deadlines and departmental policies.
Skill Development: Training programs, workshops, and seminars relevant to analytical chemistry and research.
Exposure to Advanced Techniques: Hands-on experience with SFC, chiral method development, and other cutting-edge analytical methods.
Growth Opportunities: Potential for promotions to Senior Scientist or Team Leader roles based on performance.
Transportation/Travel Allowance: Depending on company policies and location.
Recognition Programs: Rewards for outstanding contributions to research projects.
A premier global Contract Research, Development & Manufacturing Organization (CRDMO), Jubilant Biosys delivers integrated services spanning drug discovery through GMP-scale manufacturing. The company offers end-to-end solutions—from target discov... Read More